Nurse talking a patient in bed

Zantac Linked to Bladder Cancer

A Colorado man filed a lawsuit in October against the producers of Zantac (Ranitidine), alleging that his regular use of the drug resulted in bladder cancer. Mark Blake began taking Zantac in 1996 four times a week, and was diagnosed with cancer in 2018. There have been many similar lawsuits against the companies that manufacture Ranitidine since it was petitioned for recall in September 2019. Routine testing of samples showed excessive levels of the carcinogen N-nitrosodimethylamine (NDMA), and further tests demonstrated that those levels could increase when Ranitidine was ingested.

In fact, research from as early as 1981 shows that Ranitidine can produce high levels of NDMA. Mr. Blake’s case states that therefore “this was not done by accident or through some justifiable negligence. Rather, Defendants knew that it could turn a profit by convincing consumers that Zantac was harmless to humans, and that full disclosure of the true risks of Zantac would limit the amount of money Defendants would make selling Zantac.” There is additional research that demonstrates the specific link between NDMA and bladder cancer, including varied studies from Spain, Canada, and Iowa.

Following the case in Colorado, Joseph Balistreri filed a lawsuit in November against Ranitidine drug makers for causing his bladder cancer. He started taking over-the-counter Zantac in 2000 about two or three times per week, up until he heard about the recall in late 2019. He was diagnosed with bladder cancer in November 2018.

What Additional Types of Cancers are being Linked to using Zantac?

Zantac and similar drugs have been used (and marketed as safe) since Ranitidine was introduced to the market in the 1980s. Many individuals who suffer from heartburn, indigestion, acid reflux and similar symptoms have been treating their discomfort with the drug for years or even decades.

Zantac may be tied to various types of cancers, since the formation of NDMA following the ingestion of Zantac (Ranitidine) may occur throughout different areas of the body.

Those unfortunate enough to have developed nay of the following cancers due to regular and prolonged usage of Zantac or similar heartburn medications may be eligible to receive compensation:

  • Stomach cancer

  • Liver cancer

  • Esophageal/colorectal cancer

  • Kidney/renal cancer

  • Leukemia

  • Multiple Myeloma

  • Non-Hodgkin's Lymphoma

  • Pancreatic cancer

  • Prostate cancer

  • Small intestine cancer

How Can We Help?

If you or a loved one has developed one of the above cancers after using Zantac (ranitidine), make sure to contact us at Kwartler Manus. Our dedicated attorneys have experience representing clients in similar cases. By filing/joining a mass tort claim against Zantac, you may be able to get compensation for your damages and protect others from future threats. Our attorneys will be by your side to help you navigate this complex process with ease and help you win the money you deserve.

Don’t hesitate to pursue the compensation you deserve to make up for these pharmaceutical companies’ mistakes. Contact us today to schedule a free consultation and learn your rights.


Put Us On Your Side

  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.